Patents Assigned to FL Therapeutics, LLC
  • Patent number: 9150585
    Abstract: The present invention provides novel conjugates of camptothecin and camptothecin analogs with a linker and an HSA-binding moiety. The novel conjugates are prodrug forms of the camptothecin or camptothecin analogs and can be used to treat mammalian cell proliferative diseases, such as cancer.
    Type: Grant
    Filed: November 11, 2013
    Date of Patent: October 6, 2015
    Assignee: FL Therapeutics LLC
    Inventor: Qun Sun
  • Patent number: 8748610
    Abstract: A kind of new compounds, and their pharmaceutically acceptable salts, and hydrates are disclosed. The pharmaceutical composition thereof is also provided. And also are the medical uses of the compounds, pharmaceutically acceptable salts, hydrates and the pharmaceutical composition for treating the TRPV1-mediate diseases.
    Type: Grant
    Filed: September 27, 2010
    Date of Patent: June 10, 2014
    Assignee: FL Therapeutics LLC
    Inventor: Qun Sun
  • Publication number: 20140135356
    Abstract: The present invention provides novel conjugates of camptothecin and camptothecin analogs with a linker and an HSA-binding moiety. The novel conjugates are prodrug forms of the camptothecin or camptothecin analogs and can be used to treat mammalian cell proliferative diseases, such as cancer.
    Type: Application
    Filed: November 11, 2013
    Publication date: May 15, 2014
    Applicant: FL Therapeutics, LLC
    Inventor: Qun Sun